We have developed twin assays
SAT - SIT technology will find applications in rapid screening of samples for other hemagglutinating emerging viruses of animals and humans
We have developed twin assays ( slide agglutination test [ SAT ] for CPV antigen and slide inhibition test [ SIT ] for CPV antibody ) that are sensitive , specific , cost - effective , generic for all genotypes of CPV , and provide instant results for CPV antigen detection in feces and antibody quantification in serum .
SAT - SIT technology will find applications in rapid screening of samples for other hemagglutinating emerging viruses of animals and humans ( influenza virus and severe acute respiratory syndrome coronavirus ) .